Number of the records: 1  

The selective P-TEFb inhibitor CAN508 targets angiogenesise

  1. 1.
    0368596 - ÚEB 2012 RIV FR eng J - Journal Article
    Kryštof, Vladimír - Rárová, Lucie - Liebl, J. - Zahler, S. - Jorda, Radek - Voller, Jiří - Cankař, Petr
    The selective P-TEFb inhibitor CAN508 targets angiogenesise.
    European Journal of Medicinal Chemistry. Roč. 46, č. 9 (2011), s. 4289-4294. ISSN 0223-5234. E-ISSN 1768-3254
    R&D Projects: GA ČR GA204/08/0511; GA ČR GA301/08/1649
    Institutional research plan: CEZ:AV0Z50380511
    Keywords : Angiogenesis * Cancer * Transcription * Inhibitor * Cyclin-dependent kinase 9
    Subject RIV: CE - Biochemistry
    Impact factor: 3.346, year: 2011
    Permanent Link: http://hdl.handle.net/11104/0202895
     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.